Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boryana M Eastman

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Journal of Neurosurgical Sciences|April 10, 2020
Stereotactic radiosurgery in the treatment of adults with metastatic brain tumorsBoryana M Eastman, Vyshak A Venur, Simon S Lo, et al.
Cellular Signalling|May 24, 2012
A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogenBoryana M Eastman, Minji Jo, Drue L Webb, et al.
Cancer Research|October 14, 2010
Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cellsMinji Jo, Boryana M Eastman, Drue L Webb, et al.
The American Journal of Pathology|October 15, 2014
uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophagesJingjing Hu, Minji Jo, Boryana M Eastman, et al.
BMC Cancer|May 27, 2021
Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume centerBoryana M Eastman, Daniel S Hippe, Landon S Wootton, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Journal of Neurosurgical Sciences|April 10, 2020
Stereotactic radiosurgery in the treatment of adults with metastatic brain tumorsBoryana M Eastman, Vyshak A Venur, Simon S Lo, et al.
Cellular Signalling|May 24, 2012
A transformation in the mechanism by which the urokinase receptor signals provides a selection advantage for estrogen receptor-expressing breast cancer cells in the absence of estrogenBoryana M Eastman, Minji Jo, Drue L Webb, et al.
Cancer Research|October 14, 2010
Cell signaling by urokinase-type plasminogen activator receptor induces stem cell-like properties in breast cancer cellsMinji Jo, Boryana M Eastman, Drue L Webb, et al.
The American Journal of Pathology|October 15, 2014
uPAR induces expression of transforming growth factor β and interleukin-4 in cancer cells to promote tumor-permissive conditioning of macrophagesJingjing Hu, Minji Jo, Boryana M Eastman, et al.
BMC Cancer|May 27, 2021
Socio-economic factors do not affect overall survival in soft tissue sarcoma when patients treated at a single high-volume centerBoryana M Eastman, Daniel S Hippe, Landon S Wootton, et al.
Pageof 1